A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants
Public ClinicalTrials.gov record NCT02555878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Rivaroxaban Prophylaxis Compared With Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that rivaroxaban is superior to placebo for reducing the risk of the primary composite outcome as defined by objectively confirmed symptomatic lower extremity proximal deep vein thrombosis (DVT), asymptomatic lower extremity proximal DVT, symptomatic lower extremity distal DVT, symptomatic upper extremity DVT, symptomatic non-fatal pulmonary embolism (PE), incidental PE, and venous thromboembolism (VTE)-related death in ambulatory adult participants with various cancer types receiving systemic cancer therapy who are at high risk of developing a VTE.
Study identification
- NCT ID
- NCT02555878
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 841 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2015
- Primary completion
- Aug 23, 2018
- Completion
- Aug 23, 2018
- Last update posted
- Sep 11, 2019
2015 – 2018
United States locations
- U.S. sites
- 70
- U.S. states
- 30
- U.S. cities
- 70
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Martinez | California | — | — |
| Not listed | Santa Barbara | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Norwich | Connecticut | — | — |
| Not listed | Gainesville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Miami Shores | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Evanston | Illinois | — | — |
| Not listed | Joliet | Illinois | — | — |
| Not listed | Peoria | Illinois | — | — |
| Not listed | Rockford | Illinois | — | — |
| Not listed | Skokie | Illinois | — | — |
| Not listed | Urbana | Illinois | — | — |
| Not listed | Anderson | Indiana | — | — |
| Not listed | Cedar Rapids | Iowa | — | — |
| Not listed | Brewer | Maine | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Silver Spring | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Rochester | Minnesota | — | — |
| Not listed | Saint Cloud | Minnesota | — | — |
| Not listed | Kansas City | Missouri | — | — |
| Not listed | Grand Island | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Lebanon | New Hampshire | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | East Syracuse | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | The Bronx | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | High Point | North Carolina | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Erie | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | North Charleston | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Abilene | Texas | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Beaumont | Texas | — | — |
| Not listed | Bedford | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Denton | Texas | — | — |
| Not listed | Flower Mound | Texas | — | — |
| Not listed | Garland | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Paris | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Sugar Land | Texas | — | — |
| Not listed | Temple | Texas | — | — |
| Not listed | The Woodlands | Texas | — | — |
| Not listed | Tyler | Texas | — | — |
| Not listed | Waco | Texas | — | — |
| Not listed | Roanoke | Virginia | — | — |
| Not listed | Winchester | Virginia | — | — |
| Not listed | Green Bay | Wisconsin | — | — |
| Not listed | Weston | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02555878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2019 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02555878 live on ClinicalTrials.gov.